retatrutide study sign up trial: 45% of patients lost over 30% of their body weight Eli Lilly's Anticipated Weight Loss

Remember, these doses suit research settings only

Assessing Thyroid Cancer Risk With GLP-1 Therapy Ariana Pelosci Russ Conroy Gary L

Several products marketed as natural weight loss aids have been found to contain illicit or previously withdrawn pharmaceutical ingredients, which can lead to serious side effects or dangerous interactions

As an obesity medicine physician scientist who regularly cares for patients with complex inflammatory conditions, this study reinforces what many of us have suspected clinicallythat the benefits of GLP-1 receptor agonists extend well beyond blood sugar control and weight loss and may fundamentally alter the disease trajectory for some of our highest-risk patients. Although this study cannot prove a causal link between GLP-1 medication and the effects seen on the patients taking them, it opens the door to future combinations of treatments for autoimmune disease with GLP-1 drugs